Farther Finance Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$345 Buy
80
+2
+3% +$9 ﹤0.01% 5806
2026
Q2
$357 Buy
78
+77
+7,700% +$306 ﹤0.01% 5605
2026
Q1
$4 Buy
+1
New +$5 ﹤0.01% 5717

Other funds holding TLSI

Farther Finance Advisors's TLSI Position: Q3 2026 in Review

Farther Finance Advisors increased its TriSalus Life Sciences (TLSI) stake by 2.6% in Q3 2026, buying an estimated $9 and bringing the position to 80 shares worth $345. The position accounts for ﹤0.01% of the portfolio, ranked #5806.

Farther Finance Advisors first reported a position in TLSI in Q1 2026 and has held it in 3 quarters since. The position peaked at $357 in Q2 2026. 2 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • Farther Finance Advisors held 80 shares of TriSalus Life Sciences worth $345 as of Q3 2026.
  • Farther Finance Advisors bought 2 TriSalus Life Sciences shares in Q3 2026, an estimated $9.
  • TriSalus Life Sciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5806 holding.
  • Farther Finance Advisors first reported a position in TriSalus Life Sciences in Q1 2026 and has held it in 3 quarters since.
  • Farther Finance Advisors's TriSalus Life Sciences position peaked at $357 in Q2 2026.
  • 2 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.